Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis

• Published in: Scientific reports 2021-01, Vol.11 (1), p.2416-2416, Article 2416
• Main Authors: Bo, Chunrui, Zhang, Huixue, Cao, Yuze, Lu, Xiaoyu, Zhang, Cong, Li, Shuang, Kong, Xiaotong, Zhang, Xiaoming, Bai, Ming, Tian, Kuo, Saitgareeva, Aigul, Lyaysan, Gaysina, Wang, Jianjian, Ning, Shangwei, Wang, Lihua
• Format: Article
• Language: English
• Subjects: 17β-Estradiol; 631/114/2164; 692/617/375; Autoimmune diseases; Biomarkers; Drugs; Estrogen receptors; Genes; Humanities and Social Sciences; miRNA; Molecular modelling; multidisciplinary; Myasthenia gravis; Myc protein; Neuromuscular diseases; Neuromuscular junctions; Raloxifene; Science; Science (multidisciplinary); Statistical analysis; Tamoxifen; Transcription factors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-81962-6

Myasthenia gravis (MG) is an autoimmune disease and the most common type of neuromuscular disease. Genes and miRNAs associated with MG have been widely studied; however, the molecular mechanisms of transcription factors (TFs) and the relationship among them remain unclear. A TF–miRNA–gene network (TMGN) of MG was constructed by extracting six regulatory pairs (TF–miRNA, miRNA–gene, TF–gene, miRNA–TF, gene–gene and miRNA–miRNA). Then, 3/4/5-node regulatory motifs were detected in the TMGN. Then, the motifs with the highest Z-score, occurring as 3/4/5-node composite feed-forward loops (FFLs), were selected as statistically significant motifs. By merging these motifs together, we constructed a 3/4/5-node composite FFL motif-specific subnetwork (CFMSN). Then, pathway and GO enrichment analyses were performed to further elucidate the mechanism of MG. In addition, the genes, TFs and miRNAs in the CFMSN were also utilized to identify potential drugs. Five related genes, 3 TFs and 13 miRNAs, were extracted from the CFMSN. As the most important TF in the CFMSN, MYC was inferred to play a critical role in MG. Pathway enrichment analysis showed that the genes and miRNAs in the CFMSN were mainly enriched in pathways related to cancer and infections. Furthermore, 21 drugs were identified through the CFMSN, of which estradiol, estramustine, raloxifene and tamoxifen have the potential to be novel drugs to treat MG. The present study provides MG-related TFs by constructing the CFMSN for further experimental studies and provides a novel perspective for new biomarkers and potential drugs for MG.